colistin polymyxin E
Selected indexed studies
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). (Pharmacotherapy, 2019) [PMID:30710469]
- Colistin (Polymyxin E) Use in Abdominal Solid Organ Transplant Recipients. (J Pharm Pract, 2023) [PMID:35201947]
- Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). (Emerg Microbes Infect, 2020) [PMID:32284036]
_Worker-drafted node — pending editorial review._
Connections
colistin polymyxin E is a side effect of
Sources
- Polymyxin B versus colistin: an update. (2015) pubmed
- Colistin and polymyxin B: peas in a pod, or chalk and cheese? (2014) pubmed
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). (2019) pubmed
- Colistin (Polymyxin E) Use in Abdominal Solid Organ Transplant Recipients. (2023) pubmed
- Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). (2020) pubmed
- Polymyxin B: similarities to and differences from colistin (polymyxin E). (2007) pubmed
- Enhancing the effectiveness of Polymyxin E with a Fisetin Nanoemulsion against a Colistin-resistant Salmonella typhimurium infection. (2024) pubmed
- Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? (2016) pubmed
- Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin. (2024) pubmed
- (E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii. (2024) pubmed